Guillermo Delmonte

Guillermo Delmonte is a seasoned professional with extensive experience in business development and finance across various sectors. As Co-Founder and Managing Partner at NDLATAM since February 2015, Delmonte focuses on Latin American opportunities and project finance. Currently serving as a Board Advisor for Xeptiva Therapeutics, an innovative biotech company, Delmonte has also held significant roles such as Chief Operating Officer at RAMM Pharma, Director at NettaLife, and President of International Business Development at Organigram Inc. Additionally, Delmonte co-founded ICC Labs Inc., worked as a Private Banking Relationship Manager at BBVA, and served as a Senior Financial Analyst at Techint Group. Academic qualifications include a Certified Public Accountant degree from Universidad ORT Uruguay and specialized courses in finance from Universidad de Montevideo.